124 related articles for article (PubMed ID: 19800717)
1. Clinicopathological behaviour of multiple oral dysplastic lesions compared with that of single lesions.
Hamadah O; Goodson ML; Thomson PJ
Br J Oral Maxillofac Surg; 2010 Oct; 48(7):503-6. PubMed ID: 19800717
[TBL] [Abstract][Full Text] [Related]
2. Predicting recurrence after oral precancer treatment: use of cell cycle analysis.
Thomson PJ; Hamadah O; Goodson ML; Cragg N; Booth C
Br J Oral Maxillofac Surg; 2008 Jul; 46(5):370-5. PubMed ID: 18282643
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
4. Malignant transformation of leukoplakia three times in period of 11-years--case report.
Amino K; Tsubakimoto Y; Doi T; Sakuda M
J Osaka Univ Dent Sch; 1995 Dec; 35():13-20. PubMed ID: 9206463
[TBL] [Abstract][Full Text] [Related]
5. Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications.
Wang YP; Chen HM; Kuo RC; Yu CH; Sun A; Liu BY; Kuo YS; Chiang CP
J Oral Pathol Med; 2009 Sep; 38(8):651-6. PubMed ID: 19656267
[TBL] [Abstract][Full Text] [Related]
6. Cancerisation within the oral cavity: the use of 'field mapping biopsies' in clinical management.
Thomson PJ; Hamadah O
Oral Oncol; 2007 Jan; 43(1):20-6. PubMed ID: 16757199
[TBL] [Abstract][Full Text] [Related]
7. Pre-malignant lesions of the oral mucosa in a South African sample--a clinicopathological study.
Feller L; Altini M; Slabbert H
J Dent Assoc S Afr; 1991 May; 46(5):261-5. PubMed ID: 1962315
[TBL] [Abstract][Full Text] [Related]
8. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and correlation of the clinicopathological features in oral epithelial dysplasia: analysis of 173 cases.
Pereira Jdos S; Carvalho Mde V; Henriques AC; de Queiroz Camara TH; Miguel MC; Freitas Rde A
Ann Diagn Pathol; 2011 Apr; 15(2):98-102. PubMed ID: 21190879
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features and immunohistochemical expression of p53, Ki-67, Mcm-2 and Mcm-5 in proliferative verrucous leukoplakia.
Gouvêa AF; Vargas PA; Coletta RD; Jorge J; Lopes MA
J Oral Pathol Med; 2010 Jul; 39(6):447-52. PubMed ID: 20412398
[TBL] [Abstract][Full Text] [Related]
11. Field change and oral cancer: new evidence for widespread carcinogenesis?
Thomson PJ
Int J Oral Maxillofac Surg; 2002 Jun; 31(3):262-6. PubMed ID: 12190131
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
Schepman KP; van der Meij EH; Smeele LE; van der Waal I
Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
[TBL] [Abstract][Full Text] [Related]
14. [Precancerous lesions of the buccal mucosa].
Ben Slama L
Rev Stomatol Chir Maxillofac; 2001 Apr; 102(2):77-108. PubMed ID: 11446145
[TBL] [Abstract][Full Text] [Related]
15. Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management.
Thomson PJ; Wylie J
Int J Oral Maxillofac Surg; 2002 Apr; 31(2):145-53. PubMed ID: 12102411
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting carbon dioxide laser treatment for oral precancer: a patient cohort study.
Hamadah O; Thomson PJ
Lasers Surg Med; 2009 Jan; 41(1):17-25. PubMed ID: 19143013
[TBL] [Abstract][Full Text] [Related]
17. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions.
Poomsawat S; Buajeeb W; Khovidhunkit SO; Punyasingh J
J Oral Pathol Med; 2010 Nov; 39(10):793-9. PubMed ID: 20618617
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters.
Raju B; Mehrotra R; Oijordsbakken G; Al-Sharabi AK; Vasstrand EN; Ibrahim SO
Anticancer Res; 2005; 25(6C):4699-706. PubMed ID: 16334163
[TBL] [Abstract][Full Text] [Related]
19. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
20. [Histochemical study of lectin receptor and cell morphometric analysis on oral leukoplakias, epithelial dysplasia and squamous carcinoma].
Jiang Y; Wu Y; Wang F
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):351-3. PubMed ID: 9592290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
